title: Baculoviral capsid display of His-tagged ZnO inorganic binding peptide.
abstract: Virus-templated fabrication of compound structures can be made through incorporating the specifically inorganic-binding peptide into the viral scaffold, widely used is phage display system. Compared to prokaryotic phages, insect cell-based baculovirus has some strengths such as the adaptability to the proteins' posttranslational modification and non-replication in mammalian cells. As an attempt to explore the baculovirus-mediated bioconjugates, we show in this study that a genetically engineered baculovirus, with a hexahistidine (His(6)) tagged ZnO binding peptide fused to the N-terminus of the viral capsid protein vp39 of AcNPV, was constructed. It maintains both the viral infectivity and the fusion protein's activity. The presence of the fusion protein on the baculovirus particle was demonstrated by western blot analysis of purified budded virus. Its display on the virus capsid was revealed by virus fractionation analysis. The binding of nanosized ZnO powders to the virus capsid was visualized by transmission electron microscopy (TEM). This is the first report of the display of the inorganic-binding peptide on the capsid of eukaryotic baculovirus. Aimed at the nanomaterials' application in the biological field, this research could find useful in the biotracking of the baculovirus transduction process and the preparation of novel functional nanodevices.
authors.affiliation: College of Life Science and Technology, Beijing University of Chemical Technology, 100029, Beijing, China, slof-songlei@163.com.
authors.forename: Lei
authors.initials: L
authors.lastname: Song
authors.forename: Yingying
authors.initials: Y
authors.lastname: Liu
authors.forename: Jinchun
authors.initials: J
authors.lastname: Chen
references.citation: J Bone Miner Res. 1997 Feb;12(2):221-7
references.pmid: 9041053
references.citation: Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14183-5
references.pmid: 10588672
references.citation: Appl Environ Microbiol. 2000 Jan;66(1):10-4
references.pmid: 10618196
references.citation: Curr Gene Ther. 2008 Feb;8(1):54-65
references.pmid: 18336250
references.citation: Mol Ther. 2003 Nov;8(5):853-62
references.pmid: 14599820
references.citation: Nat Nanotechnol. 2006 Oct;1(1):72-7
references.pmid: 18654145
references.citation: Nucleic Acids Res. 2003 Sep 1;31(17):e101
references.pmid: 12930975
references.citation: Biochem Biophys Res Commun. 1997 Sep 29;238(3):717-22
references.pmid: 9325155
references.citation: Virology. 1998 May 25;245(1):99-109
references.pmid: 9614871
references.citation: Trends Biotechnol. 2001 Jun;19(6):231-6
references.pmid: 11356285
references.citation: Biotechnology (N Y). 1995 Oct;13(10):1079-84
references.pmid: 9636281
references.citation: Biotechniques. 1997 Apr;22(4):730-5
references.pmid: 9105625
references.citation: Nat Biotechnol. 1997 Mar;15(3):269-72
references.pmid: 9062928
references.citation: J Nanosci Nanotechnol. 2002 Feb;2(1):95-100
references.pmid: 12908327
references.citation: Biotechnol Bioeng. 2004 Jul 20;87(2):129-37
references.pmid: 15236241
references.citation: Chem Rev. 2001 Oct;101(10):3205-18
references.pmid: 11710069
references.citation: Nature. 1996 Aug 15;382(6592):607-9
references.pmid: 8757129
references.citation: Science. 2002 May 3;296(5569):892-5
references.pmid: 11988570
references.citation: Science. 2004 Jan 9;303(5655):213-7
references.pmid: 14716009
references.citation: Curr Opin Biotechnol. 2001 Aug;12(4):395-9
references.pmid: 11551469
references.citation: Acta Pharmacol Sin. 2005 Apr;26(4):405-16
references.pmid: 15780188
references.citation: Nano Lett. 2005 Jul;5(7):1429-34
references.pmid: 16178252
references.citation: Nat Mater. 2003 Sep;2(9):577-85
references.pmid: 12951599
references.citation: Virology. 1994 Jul;202(1):315-28
references.pmid: 8009843